• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Pernix Therapeutics Holdings Inc

+ Add to Watchlist

PTX:US

9.7600 USD 0.5600 6.09%

As of 20:10:00 ET on 12/17/2014.

Company Profile for Pernix Therapeutics Holdings Inc (PTX)

Pernix Therapeutics Holdings, Inc. manufactures pharmaceuticals. The Company acquires, develops and markets medications for the pediatric market including treatments for dermatitis, statin-induced ubiquinone deficiency, deficiencies in active cultures due to diet and antibiotics, and upper respiratory conditions.

Contact Information

Pernix Therapeutics Holdings Inc

10 Park Place Suite 201
Morristown, NJ 07960
United States
Phone: 800-793-2145

Key Executives for Pernix Therapeutics Holdings Inc (PTX)

Douglas Drysdale "Doug"Chairman/President/CEOSanjay S PatelChief Financial Officer
Terence S Novak "Terry"Chief Operating OfficerBrian T DorseySenior VP:Pharmaceutical Dev
Rick ShalabySenior VP:SalesTracy S CliffordVP:Accounting/Treasurer/Secy
Jessica OienVP:Compliance

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil